Discover the detailed record of transactions filed by ANNE-JULIETTE HERMANT, Chief People Officer and Member of the Executive Board. Insider active across 1 companies, notably NANOBIOTIX. Aggregated, 1 disclosures have been recorded. The latest transaction was disclosed on 27 June 2025 — Attribution gratuite d'actions. Regulator: AMF. The full history is openly available.
1 of 1 declaration
Anne-Juliette Hermant is a French executive specialized in human resources, talent management, and leadership development within large international groups. At Nanobiotix, she serves as Chief People Officer and sits on the Executive Board, where she plays a strategic role in shaping the company’s human capital. In a publicly listed biotechnology company focused on oncology and nanomedicine, her remit is essential: attracting top scientific and corporate talent, strengthening leadership capabilities, and supporting organizational performance in a highly regulated and international environment. Before joining Nanobiotix, Anne-Juliette Hermant built more than 14 years of experience at AXA across multiple talent and development functions. She spent three years at AXA Partners as Global Head of Talent, Development, Culture and Corporate Responsibility. Prior to that, she served as Chief Learning Officer of the AXA Group, where she was responsible for learning strategy and large-scale capability development. One of her most notable achievements was founding and leading the AXA Research Fund, a €100 million fund created by the AXA Group to support frontier scientific research on the risks faced by human society. This initiative highlights her ability to combine HR strategy with long-term scientific and societal impact, bridging corporate leadership and innovation-oriented philanthropy. Her academic background further reflects this distinctive profile. Anne-Juliette Hermant studied French literature at the École Normale Supérieure and Politics at Sciences Po Paris. Born in Strasbourg and raised across several French Caribbean territories, she brings a broad cultural perspective and adaptability to her leadership style. At Nanobiotix, she represents a senior people-leadership profile aligned with the company’s international ambitions and growth trajectory.